Get the Stockscreener App
5.34
1.29%
-0.07
Neuberger Berman High Yield Strategies Fund Stock (NHS) Forecast
The Neuberger Berman High Yield Strategies Fund (NHS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $5.3842, representing a +0.83% increase from the current price of $5.34. The highest analyst price target is $5.7393, and the lowest is $5.029.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NHS Price Target
Average 3.1037
(-41.88% Downside)
Is Neuberger Berman High Yield Strategies Fund (NHS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 27.19 | Buy |
| STOCH(9,6) | 40.89 | Neutral |
| STOCHRSI(14) | 61.09 | Neutral |
| MACD(12,26) | -0.1071 | Buy |
| ADX(14) | 61.44 | Sell |
| William %R | -90.40 | Buy |
| CCI(14) | -43.73 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
5.4135
Sell
|
5.4207
Sell
|
| MA20 |
5.4653
Sell
|
5.493
Sell
|
| MA50 |
5.7617
Sell
|
5.6997
Sell
|
| MA100 |
5.9768
Sell
|
5.9552
Sell
|
| MA200 |
6.4972
Sell
|
6.3321
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, NHS could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 11 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on NHS, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 27.19 indicates that NHS is oversold. This indicates that NHS price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 40.89 indicates that NHS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 61.09 indicates that NHS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 61.44 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -43.73 indicates that NHS is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term NHS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Neuberger Berman High Yield Strategies Fund financial reports and earnings history, Neuberger Berman High Yield Strategies Fund (NHS) stock could reach $3.3613 by 2030, $10.61 by 2040 and $24.30 by 2050. See the projected annual prices until 2050 of the Neuberger Berman High Yield Strategies Fund stock below:
- Neuberger Berman High Yield Strategies Fund (NHS) is expected to reach an average price of $3.0059 in 2035, with a high prediction of $3.2045 and a low estimate of $3.1159. This indicates an $-43.71% rise from the last recorded price of $5.34.
- Neuberger Berman High Yield Strategies Fund (NHS) stock is projected to chart a bullish course in 2040, with an average price target of $10.64, representing an $99.18% surge from its current level. The forecast ranges from a conservative $10.65 to a sky-high $10.61.
- Our analysts predict Neuberger Berman High Yield Strategies Fund (NHS) to jump 225.74% by 2045, soaring from $17.58 to an average price of $17.39, potentially reaching $18.25. While $17.58 is the low estimate, the potential upside is significant.
- Neuberger Berman High Yield Strategies Fund (NHS) stock is expected to climb by 2050, reaching an average of $25.25, a $372.87% jump from its current level. However, a wide range of estimates exists, with high and low targets of $24.30 and $24.27, respectively, highlighting the market's uncertainty.
Neuberger Berman High Yield Strategies Fund Stock (NHS) Year by Year Forecast
Neuberger Berman High Yield Strategies Fund Stock (NHS) Price Forecast for 2026
The predicted value for Neuberger Berman High Yield Strategies Fund (NHS) in 2026 is set at an average of $6.2542. Estimates vary from a peak of $7.75 to a trough of $4.7584, indicating an +17.12% surge from the present price of $5.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $5.049 | $5.029 | $5.7393 | -5.45% |
| December, 2026 | $4.8483 | $4.7584 | $5.4434 | -9.21% |
Neuberger Berman High Yield Strategies Fund Stock (NHS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Neuberger Berman High Yield Strategies Fund (NHS) is $2.9557, with a high forecast of $5.4434 and a low forecast of $0.4681. This indicates an -44.65% decrease from the last price of $5.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.6276 | $4.5976 | $5.4434 | -13.34% |
| February, 2027 | $3.907 | $3.6673 | $4.5825 | -26.84% |
| March, 2027 | $3.8211 | $3.3465 | $4.0911 | -28.44% |
| April, 2027 | $4.2804 | $3.0308 | $4.3603 | -19.84% |
| May, 2027 | $2.6946 | $2.6946 | $5.1049 | -49.54% |
| June, 2027 | $2.1439 | $1.6539 | $2.8894 | -59.85% |
| July, 2027 | $0.9733 | $0.8633 | $2.3284 | -81.77% |
| August, 2027 | $1.3974 | $0.4681 | $1.6474 | -73.83% |
| September, 2027 | $2.8267 | $1.4102 | $3.0067 | -47.06% |
| October, 2027 | $2.1461 | $1.7661 | $2.8915 | -59.81% |
| November, 2027 | $1.4302 | $1.0654 | $2.2257 | -73.22% |
| December, 2027 | $1.5895 | $0.7451 | $1.61 | -70.23% |
Neuberger Berman High Yield Strategies Fund Stock (NHS) Price Forecast for 2028
In 2028, Neuberger Berman High Yield Strategies Fund (NHS) is projected to reach an average price of $2.2129, with a high projection of $3.0168 and a low estimate of $1.409. This indicates an -58.56% fall from the last price of $5.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.5537 | $1.4644 | $2.5637 | -52.18% |
| February, 2028 | $2.153 | $1.793 | $2.6685 | -59.68% |
| March, 2028 | $2.3024 | $1.9379 | $2.5175 | -56.88% |
| April, 2028 | $2.8317 | $2.3122 | $3.0168 | -46.97% |
| May, 2028 | $1.7558 | $1.7558 | $2.8565 | -67.12% |
| June, 2028 | $2.4452 | $1.5055 | $2.4852 | -54.21% |
| July, 2028 | $2.3393 | $2.3093 | $2.95 | -56.19% |
| August, 2028 | $1.5186 | $1.409 | $2.4241 | -71.56% |
| September, 2028 | $1.448 | $1.4231 | $1.6383 | -72.88% |
| October, 2028 | $1.7621 | $1.4128 | $1.8173 | -67.00% |
| November, 2028 | $1.6715 | $1.5558 | $2.0518 | -68.70% |
| December, 2028 | $1.7708 | $1.6963 | $1.9711 | -66.84% |
Neuberger Berman High Yield Strategies Fund Stock (NHS) Price Forecast for 2029
The 2029 price forecast for Neuberger Berman High Yield Strategies Fund Stock (NHS) is $2.1409 on average, with a high prediction of $3.092 and a low estimate of $1.1898. This represents an -59.91% decrease from the previous price of $5.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.3049 | $1.3049 | $1.8556 | -75.56% |
| February, 2029 | $1.8093 | $1.1898 | $1.8843 | -66.12% |
| March, 2029 | $1.9336 | $1.6688 | $1.9436 | -63.79% |
| April, 2029 | $2.2977 | $1.6732 | $2.3777 | -56.97% |
| May, 2029 | $2.5171 | $2.2375 | $2.6121 | -52.86% |
| June, 2029 | $2.6164 | $2.4419 | $2.9216 | -51.00% |
| July, 2029 | $2.6505 | $2.5157 | $2.7459 | -50.36% |
| August, 2029 | $2.5699 | $2.4749 | $2.795 | -51.88% |
| September, 2029 | $2.7292 | $2.5847 | $2.8292 | -48.89% |
| October, 2029 | $2.8234 | $2.6539 | $2.8534 | -47.13% |
| November, 2029 | $2.9427 | $2.5979 | $2.9477 | -44.89% |
| December, 2029 | $2.9268 | $2.7623 | $3.092 | -45.19% |
Neuberger Berman High Yield Strategies Fund Stock (NHS) Price Forecast for 2030
Neuberger Berman High Yield Strategies Fund Stock (NHS) is expected to reach an average price of $2.9304 in 2030, with a high forecast of $3.7255 and a low forecast of $2.1353. This signifies an -45.12% decrease from the last price of $5.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.2662 | $2.9517 | $3.3613 | -38.84% |
| February, 2030 | $3.7255 | $3.171 | $3.7255 | -30.23% |
| March, 2030 | $3.1598 | $3.1248 | $3.7103 | -40.83% |
| April, 2030 | $2.939 | $2.8241 | $3.4796 | -44.96% |
| May, 2030 | $2.7783 | $2.7183 | $3.3538 | -47.97% |
| June, 2030 | $2.9126 | $2.753 | $3.128 | -45.46% |
| July, 2030 | $3.2518 | $2.8325 | $3.2618 | -39.11% |
| August, 2030 | $3.1311 | $3.0511 | $3.3711 | -41.37% |
| September, 2030 | $2.6053 | $2.1353 | $3.2008 | -51.21% |
| October, 2030 | $3.1946 | $2.5901 | $3.2946 | -40.18% |
| November, 2030 | $3.1039 | $2.8491 | $3.4043 | -41.87% |
| December, 2030 | $3.2881 | $3.0632 | $3.3736 | -38.43% |
0.31%
0.96%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):